GL Biochem (Shanghai) Ltd회사는 제품 목록을 제공합니다.
회사 명:
GL Biochem (Shanghai) Ltd
전화:
21-61263452
이메일:
ymbetter@glbiochem.com
국적:
China
URL:
www.glschina.com/
총 제품 수:
9981
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
제품 카탈로그
HIV-1 MN ENV-59;CNDKKFSGKGSCKNV
C66H111N21O22S2
HIV-1 MN ENV-6;LGLLMICSATEKLWV
C77H129N17O20S2
HIV-1 MN ENV-60;KFSGKGSCKNVSTVQ
C66H112N20O22S
HIV-1 MN ENV-61;KGSCKNVSTVQCTHG
C61H105N21O22S2
HIV-1 MN ENV-62;KNVSTVQCTHGIRPV
C69H119N23O21S
HIV-1 MN ENV-68;SLAEEEVVIRSENFT
C74H119N19O28
HIV-1 MN ENV-69;EEVVIRSENFTDNAK
C74H119N21O28
HIV-1 MN ENV-7;MICSATEKLWVTVYY
C84H127N17O23S2
HIV-1 MN ENV-70;IRSENFTDNAKTIIV
C75H125N21O25
HIV-1 MN ENV-71;NFTDNAKTIIVHLNE
C76H121N21O25
HIV-1 MN ENV-72;NAKTIIVHLNESVQI
C74H127N21O23
HIV-1 MN ENV-73;IIVHLNESVQINCTR
C74H127N23O23S
HIV-1 MN ENV-74;LNESVQINCTRPNYN
C73H117N23O26S
HIV-1 MN ENV-75;VQINCTRPNYNKRKR
C79H136N30O22S
HIV-1 MN ENV-76;CTRPNYNKRKRIHIG
C79H134N30O20S
HIV-1 MN ENV-77;NYNKRKRIHIGPGRA
C77H130N30O19
HIV-1 MN ENV-78;RKRIHIGPGRAFYTT
C80H129N27O19
HIV-1 MN ENV-79;HIGPGRAFYTTKNII
C78H122N22O20
HIV-1 MN ENV-8;ATEKLWVTVYYGVPV
C84H125N17O22
HIV-1 MN ENV-80;GRAFYTTKNIIGTIR
C77H127N23O21
HIV-1 MN ENV-81;YTTKNIIGTIRQAHC
C74H123N23O22S
HIV-1 MN ENV-82;NIIGTIRQAHCNISR
C70H122N26O21S
HIV-1 MN ENV-83;TIRQAHCNISRAKWN
C76H124N28O21S
HIV-1 MN ENV-84;AHCNISRAKWNDTLR
C75H121N27O22S
HIV-1 MN ENV-85;ISRAKWNDTLRQIVS
C78H131N25O23
HIV-1 MN ENV-86;KWNDTLRQIVSKLKE
C83H140N24O24
HIV-1 MN ENV-87;TLRQIVSKLKEQFKN
C82H142N24O23
HIV-1 MN ENV-88;IVSKLKEQFKNKTIV
C82H143N21O22
HIV-1 MN ENV-89;LKEQFKNKTIVFNQS
C83H134N22O24
HIV-1 MN ENV-90;FKNKTIVFNQSSGGD
C72H112N20O24
HIV-1 MN ENV-91;TIVFNQSSGGDPEIV
C68H107N17O25
HIV-1 MN ENV-92;NQSSGGDPEIVMHSF
C67H101N19O25S
HIV-1 MN ENV-93;GGDPEIVMHSFNCGG
C63H94N18O22S2
HIV-1 MN ENV-94;EIVMHSFNCGGEFFY
C82H110N18O23S2
HIV-1 MN ENV-95;HSFNCGGEFFYCNTS
C75H97N19O24S2
HIV-1 MN ENV-96;CGGEFFYCNTSPLFN
C77H103N17O23S2
HIV-1 MN ENV-97;FFYCNTSPLFNSTWN
C87H113N19O24S
HIV-1 MN ENV-98;NTSPLFNSTWNGNNT
C71H103N21O26
HIV-1 MN ENV-99;LFNSTWNGNNTWNNT
C78H107N23O26
HIV-1 MN gp160 Fragment 02;LLMICSAT
C36H66N8O11S2
HIV-1 MN gp160 Fragment 03;CSATEKLWV
C46H73N11O14S
HIV-1 MN gp160 Fragment 04;EKLWVYYGVPVWKEATTT
C105H152N22O28
HIV-1 MN ENV-26;EQMHEDIISLWDQSL
C80H122N20O28S
HIV-1 MN ENV-3;NYQHWWGWGTMLLGL
C90H120N22O20S
HIV-1 MN ENV-30;PCVKLTPLCVTLNCT
C69H121N17O20S3
HIV-1 MN ENV-31;LTPLCVTLNCTDLRN
C70H122N20O23S2
HIV-1 MN ENV-32;CVTLNCTDLRNTTNT
C65H113N21O26S2
HIV-1 MN ENV-33;NCTDLRNTTNTNNST
C62H105N23O29S
HIV-1 MN ENV-34;LRNTTNTNNSTANNN
C62H105N25O28
HIV-1 MN ENV-35;TNTNNSTANNNSNSE
C57H92N22O31
HIV-1 MN ENV-36;NSTANNNSNSEGTIK
C59H99N21O28
HIV-1 MN ENV-37;NNNSNSEGTIKGGEM
C59H98N20O27S
HIV-1 MN ENV-38;NSEGTIKGGEMKNCS
C60H103N19O25S2
HIV-1 MN ENV-39;TIKIGGEMKNCSFNIT
C75H126N20O24S2
HIV-1 MN ENV-4;WWGWGTMLLGLLMIC
C86H126N18O17S3
HIV-1 MN ENV-40;GEMKNCSFNITTSIR
C70H117N21O24S2
HIV-1 MN ENV-41;NCSFNITTSIRDKMQ
C72H120N22O25S2
HIV-1 MN ENV-42;NITTSIRDKMQKEYA
C76H128N22O26S
HIV-1 MN ENV-43;SIRDKMQKEYALLYK
C85H140N22O24S
HXB2 gag #103;RKKGCWKCGKEGHQM
HXB2 gag #102/aa405-419;CRAPRKKGCWKCGKE
C73H124N26O18S3
HXB2 gag #101/aa401-415;TARNCRAPRKKGCWK
C74H127N29O18S2
HXB2 gag #100/aa397-411;KEGHTARNCRAPRKK
C71H126N30O20S
HXB2 gag #10;ASRELERFAVNPGLL
HXB2 gag #1/aa1-15;MGARASVLSGGELDR
Human prepro-gamma-tryptase (192-206);CRRDYPGPGGSILQP
C69H110N22O21S
Human Myocilin/TIGR Fragment (188-204);TRDTARAVPPGSREVST
C73H126N26O27
H-Tyr-Val-Ala-Asp-AFC;YVAD-AFC
C31H34F3N5O9
HIV-1 MN ENV-21;QEVELVNVTENFNMW
C82H122N20O27S
HIV-1 MN ENV-210;GRAILHIPTRIRQGL
C75H133N27O18
HIV-1 MN ENV-211;LHIPTRIRQGLERAL
C78H137N27O20
HIV-1 MN ENV-212;TRIRQGLERALL
C61H112N22O17
HIV-1 MN ENV-22;LVNVTENFNMWKNNM
C81H124N22O24S2
HIV-1 MN ENV-23;TENFNMWKNNMVEQM
C81H122N22O26S3
HIV-1 MN ENV-24;NMWKNNMVEQMHEDI
C80H123N23O26S3
HIV-1 MN ENV-25;NNMVEQMHEDIISLW
C80H123N21O26S2
H-Phe-Arg-AFC;FR-AFC
C25H27F3N6O4
HMGA N-Terminal Fragment;GAGQPSTSAQGQ
C42H69N15O19
HIV-1 Protease Substrate, chromogenic;Ac-RKILF(4-NO2)LDG-NH2
C47H78N14O13
HIV-1 MN gp160 Fragment 17;NDSTSYRLISCNTSV
C67H110N20O27S
HIV-1 MN gp160 Fragment 16;LYKLDIVSIDNDSTSYRLIS
C103H167N25O35
HIV-1 MN gp160 Fragment 15;REKMQKEYALLYKLDIVSID
C111H183N27O33S
HIV-1 MN gp160 Fragment 08;NFNMWKNNMVEQMHEDIISK
C108H166N30O33S3
HIV-1 MN gp160 Fragment 07;ELVNVTENFNMWK
C73H110N18O22S
HIV-1 MN gp160 Fragment 05;VPVWKEATTTLFCASDAKAY
C101H153N23O30S
HIV-1 MN ENV-44;KMQKEYALLYKLDIV
C87H143N19O23S
HIV-1 MN ENV-45;EYALLYKLDIVSIDN
C82H129N17O26
HIV-1 MN ENV-46;LYKLDIVSIDNDSTS
C73H119N17O28
HIV-1 MN ENV-47;DIVSIDNDSTSYRLI
C73H119N19O28
HIV-1 MN ENV-48;IDNDSTSYRLISCNT
C69H112N20O28S
HIV-1 MN ENV-49;STSYRLISCNTSVIT
C69H117N19O25S
HIV-1 MN ENV-5;GTMLLGLLMICSATE
C66H117N15O21S3
HIV-1 MN ENV-50;RLISCNTSVITQACP
C66H116N20O22S2
HIV-1 MN ENV-51;CNTSVITQACPKISF
C69H114N18O22S2
HIV-1 MN ENV-52;VITQACPKISFEPIP
C76H123N17O21S
HIV-1 MN ENV-53;ACPKISFEPIPIHYC
C80H120N18O20S2
HIV-1 MN ENV-54;ISFEPIPIHYCAPAG
C76H111N17O20S
HIV-1 MN ENV-56;HYCAPAGFAILKCND
C72H107N19O20S2
HIV-1 MN ENV-57;PAGFAILKCNDKKFS
C75H119N19O20S
HIV-1 MN ENV-58;AILKCNDKKFSGKGS
C69H118N20O21S
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
Copyright 2019 © ChemicalBook. All rights reserved